JACC: Basic to Translational Science (Feb 2017)

Novel Junctophilin-2 Mutation A405S Is Associated With Basal Septal Hypertrophy and Diastolic Dysfunction

  • Ann P. Quick, BA,
  • Andrew P. Landstrom, MD, PhD,
  • Qiongling Wang, PhD,
  • David L. Beavers, MD, PhD,
  • Julia O. Reynolds, BS,
  • Giselle Barreto-Torres, PhD,
  • Viet Tran, MD,
  • Jordan Showell, BS,
  • Leonne E. Philippen, MSc,
  • Shaine A. Morris MD, MPH,
  • Darlene Skapura, BS,
  • J. Martijn Bos, MD,
  • Steen E. Pedersen, PhD,
  • Robia G. Pautler, PhD,
  • Michael J. Ackerman, MD, PhD,
  • Xander H.T. Wehrens, MD, PhD

Journal volume & issue
Vol. 2, no. 1
pp. 56 – 67

Abstract

Read online

Summary: Junctophilin-2 (JPH2) is a structural calcium (Ca2+) handling protein, which approximates the cardiomyocyte transverse tubules (TTs) to the sarcoplasmic reticulum. This facilitates communication of the voltage-gated Ca2+ channel and the ryanodine receptor RyR2. A human patient with hypertrophic cardiomyopathy was positive for a JPH2 mutation substituting alanine-405—located within the alpha helix domain—with a serine (A405S). Using a novel mouse echocardiography plane, we found that mice bearing this JPH2 mutation developed increased subvalvular septal thickness. Cardiomyocytes from the septa of these mice displayed irregular TTs and abnormal Ca2+ handling including increased SERCA activity. Key Words: calcium, hypertrophic cardiomyopathy, junctophilin-2, magnetic resonance imaging